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Alcian blue, a relatively new phthalocyanine dyestuff (1), is used by industry
for dyeing cotton. In 1950 Steedman described the use of this compound for
staining mucin (2). Current evidence indicates that Alcian blue (AB) selec-
tively stains structures containing acid mucopolysaccharides (3,4). The periodic
acid Schiff (PAS) stain for 1,2 glycols, including carbohydrates, has been widely
used since the fundamental work of McManus (5) and Hotchkiss (6) in 1946
and 1948. In the present study Alcian blue was combined with the periodic acid
Schiff stain (AB-PAS) for the examination of involved skin from patients with
known collagen disease.
MATERIALS AND METHODS
Specimens of involved skin from six patients with discoid lupus erythema-
tosus, four with disseminated lupus erythematosus, four with dermatomyositis,
five with morphea, four with generalized scleroderma and five with periarteritis
nodosa, as well as several of normal skin, were examined. Specimens were
handled as follows:
1. Paraffin sections were immersed in xylene for two minutes and subse-
quently passed through absolute alcohol and 95 % alcohol to distilled water.
2. The sections were stained for 30 minutes in 0.1 % Alcian bluer in 3 % acetic
acid, washed in running tap water for 2 minutes and rinsed in distilled water. §
3. The sections were treated by the periodic acid Schiff reagent method (7)
except that hematoxylin was omitted (basic dyes used as nuclear counterstains
tend to interfere with the coloration which is produced by Alcian bluef). After
sulfurous acid rinses, the sections were washed in running tap water for five min-
utes, dehydrated in graded alcohols, cleared in xylene and mounted in balsam.
4. Another set of sections was stained with hematoxylin and eosin in the usual
fashion.
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Alcian blue can be obtained from G. T. Gurr, Ltd., London, SW. 6, England. The
dye solution should be filtered when first prepared and should have a pH of 2.5—3.0. It
performs well for several weeks. A tiny crystal of thymol is added to discourage the growth
of molds.
§ Method of Robert Mowry, Department of Pathology, University of Alabama Medical
Center, unpublished.
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Fin. 1. AB-PAS treated section from a cutaneous lesion of dermatomyositis showing
the dark staining AB positive material in the form of a cobweb-like network of delicate
fibrils in the central part of the section. X166.
FIG. 2. The same specimen as Fig. I at higher magnification. X390.
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OBSERVATIONS
The AB-PAS combination stains acid mucopolysaccharides various shades of
blue and 1,2 glycols a magenta hue (4), resulting in excellent color contrast.
The significance of the PAS stain in various collagen diseases has been examined
elsewhere (8), and the present investigation was concerned primarily with Al-
cian blue (AB) positive material in the skin from patients with collagen disease,
taking advantage of the previously noted color contrast. AB positive material,
in the form of a cobweb-like network of delicate strands which had the charac-
teristics of collagen fibrils (14), was encountered in the dermis of all specimens
examined in the course of this investigation (Figs. 1 and 2). Although the quan-
tity and distribution of AB positive material was approximately constant in the
several specimens of each individual collagen disease under consideration, there
was significant variation from one collagen disease to another. Small quantities
of AB positive material were present throughout the upper dermis in discoid
lupus erythematosus, in the near vicinity of small vessels of the upper dermis in
morphea and generalized scieroderma and throughout the upper dermis and in
close proximity to damaged vessels in periarteritis nodosa. Small quantities of
AB positive material were also present throughout the upper dermis in normal
skin. AB positive material was remarkably abundant, by contrast, in the upper
and middle dermis in dermatomyositis and disseminated lupus erythematosus.
COMMENT
Although the term "collagen disease" is a controversial one, it serves to focus
attention on the exceptional connective tissue alterations which occur in these
disorders. Mucoid change or myxomatous swelling of the ground substance and
fibrinoid alteration of the collagenous tissue are the conspicuous and tangible
changes which occur in the extracellular components of the connective tissue in
the collagen diseases.
Current evidence (9) indicates that mucoid change of the ground substance
precedes fibrinoid alteration of the collagenous tissue in this group of diseases.
The mucoid change is associated with an accumulation of acid mucopolysac-
charides (chiefly hyaluronic acid and chondroitin sulfuric acid) in the connective
tissue (9). Recent observations (10) suggest that accumulation of mucopolysac-
charides is the result of increased activity of fibroblasts. Fibrinoid alteration of
collagenous tissue is known to be preceded by a local increase in acid mucopoly-
saccharides (11) and is believed to result from a combination of acid mucopoly-
saccharides of the ground substance with protein which is derived either from
local tissue damage or from the blood (11, 12). Although the term "fibrinoid al-
teration of collagenous tissue" is well established, and has demonstrated its use-
fulness (13), it is probably not entirely accurate in the light of what is currently
known about its pathogenesis (11, 12).
AB positive material was encountered in the dermis of all specimens examined
in the course of the present investigation. A salient increase in AB positive ma-
terial was observed in the dermis from cases of dermatomyositis and dissem-
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mated lupus erythematosus, however, as compared with the other collagen dis-
eases and with normal skin. It appears, in the light of what has been said, that
acid mucopolysaccharides were present in the dermis of all specimens examined,
that they were deposited on or around the collagen fibrils or adsorbed on the
collagen fibrils and that they were greatly increased in the cutaneous lesions of
dermatomyositis and disseminated lupus erythematosus, as compared with the
other collagen diseases and with normal skin. A suitable explanation for these
observations is not presently available, although they may support the concept
of a close relationship between dermatomyositis and disseminated lupus erythe-
matosus, as compared with the other collagen diseases, from the standpoint of
metabolic alterations in the skin.
SUMMA ax
Current evidence indicates that Alcian blue, a relatively new phthalocyanine
dyestuff, selectively stains structures containing acid mucopolysaceharides. In
the present study Alcian blue was combined with the periodic acid Schiff stain
for the examination of involved skin from patients with known collagen disease.
Alcian blue positive material, in the form of a cobweb-like network of delicate
strands which had the characteristics of collagen fibrils, was encountered in all
the specimens examined in the course of this investigation. A salient increase in
Alcian blue positive material was found in the dermis from cases of dermatomy-
ositis and disseminated lupus erythematosus, as compared with the other col-
lagen diseases.
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DISCUSSION
DR. ZACHARY 1ELSHER (Chicago, Ill.): The presenter did not show us a slide
of Alcian blue stain alone. Can this Alcian blue dye stain mucopolysaccharides
and does it show the basement membrane as well as PAS stain does?
The author differentiates between collagen fibriles and collagen fibers and fi-
brinoid degeneration in the collagen itself. Studies have shown that collagen
fibers in lupus crythematosus show no change at all under the microscope. Ap-
parently the change is in the mucoid material. I wonder if the author could say
anything in regard to this.
Du. ADOLPH ROSTENBERG, JR., (Chicago, Ill.): Dr. Cawley and his colleagues
are to be congratulated on their study and their restraint. They properly r€.-
framed from endeavoring to give clinical interpretations to their data. As a dis-
cussor, it may be legitimate to speculate a little bit about the possible clinical
significance of their findings. First of all it seems to indicate that the clinical la-
bel of collagen disease includes a heterogeneous group from the pathologic point
of view. Dr. Cawley and his co-workers found a relationship between two of the
collagen diseases, namely, lupus erythematosus and dermatomyositis, but no
similar relationship among the others. Lupus erythematosus and dermatomyo-
sitis have long been related by clinicians. As you know, studies were done some
years ago on muscle changes in lupus erythematosus and dermatomyositis and
it was as a rule not possible to distinguish between the two; the differences were
quantitative and not qualitative. It has also been said that scleroderma and lu-
pus erythematosus are essentially the same disease, but Dr. Cawley's work does
not support this. From the clinical angle it has been hard for me to understand
the concept of the similarity of lupus erythematosus and seleroderma.
Dil. RICHARD B. STOUGHTON (Chicago, Ill.): I, too, feel that the primary
disease process in scleroderma is within the ground substance rather than in the
collagen fibrils. In a previous study, using other agents for metachromasia
(Stoughton, R. B. & Wells, G. C., J. Invest. Dermat., 14: 37, 1950), we were un-
able to show any ground substance alteration. However, along with Dr. Charles
Denko at the University of Chicago, we have been studying the skin metabolism
of which is injected intravenously as Na SO4. We find that the metabolism
of is very abnormal. The skin actually takes up S5 from other storage areas
in the body for a period of 3—6 weeks in the abnormal areas, whereas in normal
skin there is a continuous decline in the amount of after the first day. This
all goes along very well with what the presenters have shown with the Alcian
Blue Stain in seleroderma.
DII. J. F. A. MCMANUS, (in closing): Dr. Felsher asked about the appear-
ance of Alcian blue in normal skin: it will stain to a very slight degree the base-
ment membrane and normally it will show something resembling an occasional
fibrile of collagen but it gives a very much washed out appearance without the
possibility of recognizing too many normal structures. On the other hand, the
concentration of materials staining with Alcian blue in lupus erythematosus and
in dermatomyositis is very striking, even with Alcian blue alone, but this is
shown better with combination since one can make out more of the normal
structures with Alcian blue-PAS.
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As for fibers and fibriles and fibrinoid degeneration, I am not sure that we are
prepared to go any further into that problem than was mentioned in the paper.
Precipitation of acid mucopolysaccharides does give fibrile structures such as
were shown.
Dr. Rostenberg, I believe that the separation of two diseases with fairly strik-
ing changes from the aspect of Alcian blue staining does probably put them into
a different category from the other members of the "collagen disease" group.
How that fits into the pattern of development of our ideas I will leave to you.
Historically, in the development of information, it is a matter of getting groups
of diseases, such as Bright's disease, and finding all the varieties that have cer-
tain features in common. Perhaps that is what is happening with "collagen
diseases."
In regard to Dr. Stoughton's comments on radioactive sulphur, it is very
gratifying to learn about this. In many instances there does seem to be some Fe-
lationship to metachromasia with Toluidine blue but that is an extraordinary,
poorly understood and almost capricious stain in which with suitable handling
you can make metachromasia appear and disappear in the same tissue. From
the viewpoint of simplicity, Alcian blue does have preference after some ex-
perience.
In closing, Mr. Chairman, I would like to emphasize, as is brought out in the
paper which this group has presented, that this Alcian blue solution differs
somewhat from the stain of Steedman in that it reduces the pH and it is in a
much more dilute solution. It appears to have a good degree of sensitivity to
hyaluronic acid and the sulphate groups. It is a valuable stain not only for skin
changes, as we see here, but in investigation of mycotic diseases and of bacterial
diseases. The development of this PAS-Alcian blue stain was brought about by
Dr. Mowry, my associate at the University of Alabama, and I believe special
credit should be given to him for making available a useful new tool in the mi-
croscopic study of tissues.
